Sodium butyrate inhibits the NF‐kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL‐10 independent manner

[1]  M. Perretti,et al.  An orally administered butyrate‐releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium‐induced murine colitis , 2017, British journal of pharmacology.

[2]  Y. Yu,et al.  The Inflammation Induced by Lipopolysaccharide can be Mitigated by Short‐chain Fatty Acid, Butyrate, through Upregulation of IL‐10 in Septic Shock , 2017, Scandinavian journal of immunology.

[3]  Tenghui Zhang,et al.  Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice , 2016, Nutrients.

[4]  S. Hwang,et al.  Nimbolide Inhibits Nuclear Factor‐КB Pathway in Intestinal Epithelial Cells and Macrophages and Alleviates Experimental Colitis in Mice , 2016, Phytotherapy research : PTR.

[5]  S. Wong,et al.  Changing epidemiological trends of inflammatory bowel disease in Asia , 2016, Intestinal research.

[6]  M. Tambuwala.  Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[7]  J. S. Kim,et al.  Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis. , 2016, Life sciences.

[8]  Dongfeng Zhang,et al.  Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. , 2015, Nutrition research.

[9]  J. Greenbaum,et al.  IL-10 producing intestinal macrophages prevent excessive anti-bacterial innate immunity by limiting IL-23 synthesis , 2015, Nature Communications.

[10]  J. S. Kim,et al.  Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. , 2014, Life sciences.

[11]  K. Hase,et al.  Gut microbiota-generated metabolites in animal health and disease. , 2014, Nature chemical biology.

[12]  G. Friedlander,et al.  Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. , 2014, Immunity.

[13]  J. S. Kim,et al.  The effect of intestinal alkaline phosphatase on intestinal epithelial cells, macrophages and chronic colitis in mice. , 2014, Life sciences.

[14]  J. S. Kim,et al.  Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. , 2014, Life sciences.

[15]  R. Medzhitov,et al.  The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition , 2014, Proceedings of the National Academy of Sciences.

[16]  M. Drews,et al.  Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study , 2013, International Journal of Colorectal Disease.

[17]  W. Willett,et al.  A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. , 2013, Gastroenterology.

[18]  K. Ignatoski,et al.  Angiotensin Converting Enzyme-Inhibitor Reduces Colitis Severity in an IL-10 Knockout Model , 2013, Digestive Diseases and Sciences.

[19]  Nayoung Kim,et al.  The Effect of Helicobacter pylori on Epidermal Growth Factor Receptor-Induced Signal Transduction and the Preventive Effect of Celecoxib in Gastric Cancer Cells , 2013, Gut and liver.

[20]  Jung Mogg Kim,et al.  The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice. , 2013, Life sciences.

[21]  S. Vermeire,et al.  Butyricicoccus pullicaecorum in inflammatory bowel disease , 2012, Gut.

[22]  J. Puchalka,et al.  Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. , 2012, Gastroenterology.

[23]  H. El‐Serag,et al.  Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature , 2011, The American Journal of Gastroenterology.

[24]  Daisy M A E Jonkers,et al.  Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. , 2010, Clinical nutrition.

[25]  D. Jonkers,et al.  Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.

[26]  E. Levy,et al.  Imbalances in Dietary Consumption of Fatty Acids, Vegetables, and Fruits Are Associated With Risk for Crohn's Disease in Children , 2007, The American Journal of Gastroenterology.

[27]  T. Naoe,et al.  Sustained activation of c‐jun‐N‐terminal kinase plays a critical role in arsenic trioxide‐induced cell apoptosis in multiple myeloma cell lines , 2006, Cancer science.

[28]  R. Place,et al.  HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα , 2005 .

[29]  A. Burny,et al.  Potentiation of Tumor Necrosis Factor-Induced NF-κB Activation by Deacetylase Inhibitors Is Associated with a Delayed Cytoplasmic Reappearance of IκBα , 2003, Molecular and Cellular Biology.

[30]  A. Burny,et al.  Potentiation of Tumor Necrosis Factor-Induced NF-κB Activation by Deacetylase Inhibitors Is Associated with a Delayed Cytoplasmic Reappearance of IκBα , 2003, Molecular and Cellular Biology.

[31]  V. Koteliansky,et al.  Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis , 2002 .

[32]  Juan Zhang,et al.  Rapid development of colitis in NSAID-treated IL-10-deficient mice. , 2002, Gastroenterology.

[33]  H. Lührs,et al.  Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis , 2002, Scandinavian journal of gastroenterology.

[34]  L. Yin,et al.  Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity* , 2001, The Journal of Biological Chemistry.

[35]  Patricia Renard,et al.  Development of a sensitive multi-well colorimetric assay for active NFκB , 2001 .

[36]  W. Hörl,et al.  Anti‐inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL‐12 and up‐regulation of IL‐10 production , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  E. Bloemena,et al.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines , 1998, Clinical and experimental immunology.

[38]  J. Baker,et al.  Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial , 1996, Alimentary pharmacology & therapeutics.

[39]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[40]  T. Kirchner,et al.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. , 1992, Gastroenterology.

[41]  I. Tardivel,et al.  Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[42]  S. Ng,et al.  Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. , 2017, Gastroenterology.

[43]  Hai-hua Luo,et al.  Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. , 2016, International immunopharmacology.

[44]  P. Dolara,et al.  Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[45]  Hee-Sun Kim,et al.  Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells : Involvement of NF-κB and ERK signaling pathways , 2007 .

[46]  R. Place,et al.  HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. , 2005, Biochemical pharmacology.

[47]  L. Yin,et al.  Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. , 2001, The Journal of biological chemistry.

[48]  J. Remacle,et al.  Development of a sensitive multi-well colorimetric assay for active NFkappaB. , 2001, Nucleic acids research.